Report Categories
View AllRecent Articles
View All
CDNA CareDx delivers outsized Q1 2026 EPS beat yet shares drop 5 percent as investor sentiment cools
Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss
What AGNC AGNCP does that keeps customers coming back 028 20260508
BWNB Babcock 2026 Q4 2025 earnings outperform forecasts as EPS turns positive against projected quarterly loss